{
  "ticker": "DYN",
  "company_name": "Dyne Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04635891",
      "title": "Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)",
      "status": "RECRUITING",
      "phase": "",
      "condition": "FSHD",
      "start_date": "2020-12-15",
      "completion_date": "2028-01",
      "enrollment": 0,
      "sponsor": "University of Kansas Medical Center"
    },
    {
      "nct_id": "NCT03458832",
      "title": "Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Facioscapulohumeral Muscular Dystrophy",
      "start_date": "2018-03-05",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "University of Kansas Medical Center"
    },
    {
      "nct_id": "NCT05524883",
      "title": "Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Duchenne Muscular Dystrophy (DMD)",
      "start_date": "2022-08-12",
      "completion_date": "2029-11",
      "enrollment": 0,
      "sponsor": "Dyne Therapeutics"
    },
    {
      "nct_id": "NCT05481879",
      "title": "Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Myotonic Dystrophy Type 1 (DM1)",
      "start_date": "2022-09-05",
      "completion_date": "2029-07",
      "enrollment": 0,
      "sponsor": "Dyne Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 4,
    "by_phase": {
      "": 2,
      "PHASE1, PHASE2": 2
    },
    "by_status": {
      "RECRUITING": 3,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 4,
    "completed_trials": 0,
    "conditions": [
      "Duchenne Muscular Dystrophy (DMD)",
      "FSHD",
      "Facioscapulohumeral Muscular Dystrophy",
      "Myotonic Dystrophy Type 1 (DM1)"
    ],
    "lead_stage": "unknown"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:04.361450",
    "search_query": "Dyne Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Dyne+Therapeutics,+Inc."
  }
}